Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4

被引：0
|
作者：
Ohata, Yasuhisa [1 ]
Mori, Jun [2 ]
Fujisawa, Yasuko [3 ]
Sato, Yukihito [4 ]
Rohrich, Sebastian [5 ]
Rasmussen, Michael Hojby [6 ]
Bang, Rikke Beck [7 ]
Horikawa, Reiko [8 ]
机构：
[1] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka, Japan
[2] Osaka City Gen Hosp, Div Pediat Endocrinol & Metab, Childrens Med Ctr, Osaka, Japan
[3] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4, Japan
[4] Novo Nordisk Pharma Ltd, Tokyo, Japan
[5] Novo Nordisk AS, Zurich, Switzerland
[6] Novo Nordisk AS, Clin Drug Dev, Soborg, Denmark
[7] Novo Nordisk AS, Aalborg, Denmark
[8] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo, Japan
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2023年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FC11.5
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [41] Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
    Megumi Inoue
    Masanari Shiramoto
    Tomonori Oura
    Risa Nasu
    Masako Nakano
    Masakazu Takeuchi
    Diabetes Therapy, 2019, 10 : 1019 - 1027
  • [42] Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study
    Rudofsky, Gottfried
    Catarig, Andrei-Mircea
    Favre, Lucie
    Grau, Katrine
    Hafliger, Susan
    Thomann, Robert
    Schultes, Bernd
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [43] Immunogenicity Results of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): A Phase 2 Study in Children with Growth Hormone Deficiency
    Mendelson, Michal Jaron
    Bar-Ilan, Ahuva
    Hershkovitz, Oren
    Hart, Gili
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 371 - 371
  • [44] Real-World Assessment of Switching from a Dipeptidyl Peptidase-4 Inhibitor to Exenatide Once-Weekly in Patients with Type 2 Diabetes
    Gorgojo-Martinez, Juan J.
    Gargallo-Fernandez, Manuel A.
    Brito-Sanfiel, Miguel A.
    Lisbona-Catalan, Arturo
    DIABETES, 2017, 66 : A297 - A297
  • [45] Long-term efficacy of growth hormone therapy in prepubertal children with GH deficiency: results of a randomized dose response 4-year trial
    Cohen, Pinchas
    Weng, Wayne
    Rogol, Alan
    Rosenfeld, Ron
    Kappelgaard, Anne-Marie
    Germak, John
    HORMONE RESEARCH, 2009, 72 : 200 - 200
  • [46] Long-term Safety and Efficacy of a once-weekly Somatrogon (hGH-CTP): A 5-year Phase 2 Extension Study in Children with Growth Hormone Deficiency
    Pastrak, Aleksandra
    Choe, John
    Wajnrajch, Michael
    Cara, Jose
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 68 - 68
  • [47] Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study
    Ekberg, Neda Rajamand
    Bodholdt, Ulrik
    Catarig, Andrei-Mircea
    Catrina, Sergiu-Bogdan
    Grau, Katrine
    Holmberg, Cecilia Nagorny
    Klanger, Boris
    Knudsen, Soren Tang
    PRIMARY CARE DIABETES, 2021, 15 (05) : 871 - 878
  • [48] Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study
    Hitoshi Ishii
    Yukiko Onishi
    Tomonori Oura
    Masakazu Takeuchi
    Diabetes Therapy, 2020, 11 : 133 - 145
  • [49] Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study
    Ishii, Hitoshi
    Onishi, Yukiko
    Oura, Tomonori
    Takeuchi, Masakazu
    DIABETES THERAPY, 2020, 11 (01) : 133 - 145
  • [50] Real-world impact of once-weekly subcutaneous semaglutide after 2 years of follow-up: Results from a nationwide observational study in people with type 2 diabetes
    Vilsboll, Tina
    Lindahl, Caroline O.
    Nielsen, Nick F.
    Tikkanen, Christian K.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1740 - 1749
12345